MOESM8 of A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol...
MOESM8 of A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol...
复制标题
MOESM8%20of%20A%202%20×%202%20因子、%20随机、%20开放标签%20试验%20至%20确定%20%20临床%20和%20成本效益%20of%20高渗%20盐水%20(HTS%206
DOI：
10.6084/m9.figshare.11415417
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Bradley J
中科院分区：
文献类型：
--
作者：
Bradley J
